Skip to main content

Table 2 Overall cure rate of MSC group versus non-MSC group

From: Mesenchymal stromal cell treatment improves outcomes in children with pneumonia post-hematopoietic stem cell transplantation: a retrospective cohort study

 

Cure case (%)

Odd ratio (95% CI)

p value

Severe pneumonia

 MSC (n = 16)

12 (75.0)

6.00 (1.26–28.5)

0.020

 Non-MSC (n = 15)

5 (33.3)

Ref

 

Non-severe pneumonia

 MSC (n = 31)

31 (100.0)

–

–

 Non-MSC (n = 45)

45 (100.0)

Ref

 

All cases

 MSC (n = 47)

43 (91.5)

2.15 (0.629–7.345)

0.214

 Non-MSC (n = 60)

50 (83.3)

Ref

Â